FDA Finalizes Guidance On ‘Unique Challenges’ Of Psychedelic Research And Schedules Hearing On Therapeutic Uses
January 20, 2020 Major Canadian Pot Companies Facing Proposed Class-Action Lawsuits in the U.S. Each producer is accused of misleading investors or failing to disclose certain problems with their businesses.
